Recent industry reports reveal a promising trajectory for the global pediatric spasticity treatment market, projecting a remarkable Compound Annual Growth Rate (CAGR) of 10% from 2022 to 2032. This substantial growth underscores the expanding opportunities within a critical healthcare segment dedicated to addressing the challenges faced by children affected by pediatric spasticity. Pediatric spasticity, characterized …